Northern Trust’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Northern Trust’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-507	Closed	-$2.66K	–	4563
2023 Q3	$2.66K	Hold	507	–	–	﹤0.01%	4454
2023 Q2	$3.57K	Hold	507	–	–	﹤0.01%	4520
2023 Q1	$4.81K	Hold	507	–	–	﹤0.01%	4566
2022 Q4	$3.08K	Hold	507	–	–	﹤0.01%	4638
2022 Q3	$7K	Hold	507	–	–	﹤0.01%	4665
2022 Q2	$20K	Sell	507 -4,996	-91%	-$309K	﹤0.01%	4628
2022 Q1	$580K	Sell	5,503 -82	-1%	-$6.02K	﹤0.01%	3680
2021 Q4	$644K	Sell	5,585 -108	-2%	-$25.9K	﹤0.01%	3717
2021 Q3	$2.15M	Buy	5,693 +2,935	+106%	+$984K	﹤0.01%	3249
2021 Q2	$1.13M	Sell	2,758 -37	-1%	-$17K	﹤0.01%	3502
2021 Q1	$1.33M	Buy	+2,795	New	+$1.52M	﹤0.01%	3460

Other funds holding NEXI

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust's NEXI Position: Q4 2023 in Review

Northern Trust sold out of NexImmune, Inc. Common Stock (NEXI) in Q4 2023, closing a stake of 507 shares — an estimated $2.66K sold.

Northern Trust first reported a position in NEXI in Q1 2021 and held it in 11 quarters. The position peaked at $2.15M in Q3 2021. 11 funds tracked by Wall St. Rank hold NEXI as of Q4 2023.

Northern Trust reported no remaining NexImmune, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Northern Trust sold 507 NexImmune, Inc. Common Stock shares in Q4 2023, an estimated $2.66K.
Northern Trust first reported a position in NexImmune, Inc. Common Stock in Q1 2021 and held it in 11 quarters.
Northern Trust's NexImmune, Inc. Common Stock position peaked at $2.15M in Q3 2021.
11 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q4 2023.

Based on Northern Trust's 13F filing for Q4 2023, filed 13 Feb 2024.